Open-Label Dose Optimization of Methylphenidate Modified Release Long Acting (MPH-LA): A Post Hoc Analysis of Real-Life Titration from a 40-Week Randomized Trial

BACKGROUND AND OBJECTIVES: In the management of attention-deficit hyperactivity disorder (ADHD) in adults it is important to recognize that individual patients respond to a wide range of methylphenidate doses. Studies with methylphenidate modified release long acting (MPH-LA) in children have report...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Huss, Michael, Ginsberg, Ylva, Arngrim, Torben, Philipsen, Alexandra, Carter, Katherine, Chen, Chien-Wei, Gandhi, Preetam, Kumar, Vinod
Format: Artigo
Langue:Inglês
Publié: Springer International Publishing 2014
Sujets:
Original Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4143596/
https://ncbi.nlm.nih.gov/pubmed/25015027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-014-0213-2
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires